Biophotonics Technology, Medical Imaging, Medical Lasers, 3D Displays, LFS Crystals, Photo Detectors, 3D2D Display Technology, Laser Crystals and Components - 3D Display Demonstrated at Operational Headquarters

Vancouver, BC – March 12, 2007 – Zecotek Medical Systems Inc. (TSX-V: ZMS; Frankfurt: W1I.F) announced that it has demonstrated an animated image on its 2D3D Display at the official inauguration of its operational headquarters in Singapore. The ceremony was attended by His Excellency Alan Virtue, High Commissioner of Canada to Singapore, senior officials of the Government of Singapore, and senior members of Singapore’s business, scientific and financial communities.

“I was very impressed with their new 3D Display both for its clarity and depth,” remarked the Guest of Honour His Excellency Alan Virtue, High Commissioner of Canada to Singapore during a speech made at the inauguration. “Zecotek serves as a thriving example to Singapore and the region of their excellent technology, as well as the managerial and entrepreneurial talent that Canada has to offer. Zecotek may also serve as an example to Canadian companies of the benefits of building on Singapore’s excellent infrastructure, manufacturing base and supportive business environment as a stepping stone to going global. We look forward to many more great things from Zecotek.”

“Our 2D3D Display offers multiple viewers true volumetric visualization and exhibits depth and parallax over a wide viewing angle unlike any other 3D display available today,” said Dr. A. F. Zerrouk, Chairman, President and CEO of Zecotek. “The development and commercialization of our 2D3D Display continues to be on target and our demonstrations of the technology, including our animated image demonstration, is generating great interest.”

Zecotek opened its Singapore facilities in mid-2006 to benefit from local government cost incentives and to accelerate the commercial development of its 2D3D Display, laser, solid-state photo-detectors (MAPD) and other technologies as a base for its laser and vanadate crystal production. The facilities include 836 square meters (9,000 square feet) of lab, production and office space in Singapore’s Science Park II, located adjacent to the prestigious Institute of Microelectronics and Singapore National University. Guests at the inauguration were given a demonstration of Zecotek’s 2D3D Display, lasers and a tour of the crystal processing facilities.

“We have been delighted with the speed and efficiency of setting up in Singapore and the quality and economy of operations,” continued Dr. A. F. Zerrouk. “We came here to benefit from government incentives and to leverage Singapore’s excellent research and development efficiencies, support mechanisms and world class manufacturing facilities and we have not been disappointed. We have made tremendous strides here in the past six months and look forward to even greater successes in the immediate future.”

- 30 -

About Zecotek
Zecotek Medical Systems (TSX-V: ZMS; Frankfurt- W1I.F) is a bio-photonics technology company developing high-performance crystals, photo detectors, medical lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: medical imaging, medical lasers and 3D display and labs located in Canada, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending bio-photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders.

This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.

For additional information on Zecotek Medical Systems and our technologies please see our website at www.zecotekmed.com.

For additional information please contact:
MICHAEL MINDER
CFO; VP Corporate Development
T: (604) 827-5203
E: ir@zecotek.com

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future, please email ir@zecotek.com and mention “ZMS News” in the subject heading or visit the corporate website at www.zecotekmed.com.

Printer Friendly